Literature DB >> 18881495

The human antibody response to simultaneous injection of six specific polysaccharides of pneumococcus.

M HEIDELBERGER, C M MacLEOD, M M DI LAPI.   

Abstract

A new experimental procedure for the production of arteriosclerosis in the bird is described. The subcutaneous implantation of diethylstilbestrol by means of which a sustained increase in the concentration of cholesterol, phospholipid, and neutral fat can be readily established, is shown to induce atherosclerosis of the aorta. The atherosclerosis has been compared with that artificially induced in the bird by the prolonged feeding of cholesterol and also with that occurring spontaneously. The stilbestrol-induced lesion more closely resembled the spontaneously occurring one in the bird than did that produced by cholesterol feeding. But all 3 lesions were fundamentally similar, differing only in the amounts and proportions of the various lipid constituents present. The concentrations of cholesterol in plasma of the stilbestrol-treated and cholesterol-fed birds were of the same order. Yet cholesterol constituted a greater proportion of the lipids deposited in the arterial wall of the cholesterol-fed than in that of the stilbestrol-treated birds. This finding suggests that the cholesterol content of the vascular lesion depends not only on the absolute concentration of cholesterol in plasma, but also on the proportion of cholesterol to other lipid constituents in plasma.

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES; PNEUMOCOCCI

Mesh:

Substances:

Year:  1948        PMID: 18881495      PMCID: PMC2135821          DOI: 10.1084/jem.88.3.369

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.

Authors:  C M Macleod; R G Hodges; M Heidelberger; W G Bernhard
Journal:  J Exp Med       Date:  1945-11-30       Impact factor: 14.307

  1 in total
  10 in total

1.  Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.

Authors:  W R Usinger; A H Lucas
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  History of vaccination.

Authors:  Stanley Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 3.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

Review 4.  Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations.

Authors:  G A Bruyn; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

5.  Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

Authors:  Daniel M Musher; Adriana M Rueda; Moon H Nahm; Edward A Graviss; Maria C Rodriguez-Barradas
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

Review 6.  The COVID-19 Vaccine Landscape.

Authors:  Till Koch; Anahita Fathi; Marylyn M Addo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics.

Authors:  Stephen D Bentley; Stephanie W Lo
Journal:  Genome Med       Date:  2021-05-17       Impact factor: 11.117

8.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Absence of a prosthetic group in a type-specific polysaccharide of pneumococcus.

Authors:  M HEIDELBERGER; C M MacLEOD; H MARKOWITZ; M M DiLAPI
Journal:  J Exp Med       Date:  1951-11       Impact factor: 14.307

Review 10.  Synthetic carbohydrate-based vaccines: challenges and opportunities.

Authors:  Ravinder Mettu; Chiang-Yun Chen; Chung-Yi Wu
Journal:  J Biomed Sci       Date:  2020-01-03       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.